Expertise in
34
conditions

Dr. Saritha C. Thumma

Hematology | Oncology
601 South Sherman Street, 
Spokane, WA 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
34
conditions
601 South Sherman Street, 
Spokane, WA 

Overview

Saritha Thumma is a Hematologist and an Oncologist practicing medicine in Spokane, Washington.

Dr. Thumma is highly rated in 34 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Pleuropulmonary Blastoma, Lung Cancer, and Bone Marrow Aspiration.

She is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 2 clinical trials. Dr. Thumma is currently accepting new patients.

Specialties

Hematology
Oncology

Licenses

Internal Medicine in WI

Hospital Affiliations

Bonner General Hospital
Whitman Hospital And Medical Center
Prov Sacred Hrt Med Ctr & Childs Hosp.
Lincoln Hospital
Samaritan Hospital

Languages Spoken

English
Afrikaans
German
Hindi
Japanese
Malay
Mandarin
Polish
Spanish
Tamil
Telugu

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Coordinated Care
  • HMO
  • MANAGED MEDICAID PLAN
Group Health Cooperative
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Lifewise

Accepted plan types not found. Please verify directly with the provider.

Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Moda Health
  • EPO
  • PPO
PacificSource
  • PPO
Premera
  • EPO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 19 Less Insurance Carriers -

Locations

601 South Sherman Street, Spokane, WA 99202

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Randomized Study of Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of Patients With HER2+ Metastatic Breast Cancer Who Have Received Prior Anti-HER2 Therapies and Require Systemic Treatment
A Phase 3, Randomized Study of Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of Patients With HER2+ Metastatic Breast Cancer Who Have Received Prior Anti-HER2 Therapies and Require Systemic Treatment
Enrollment Status: Completed
Publish Date: March 17, 2025
Intervention Type: Drug, Biological
Study Drugs: Margetuximab, Trastuzumab, Capecitabine, Eribulin, Gemcitabine, Vinorelbine
Study Phase: Phase 3
A Multicenter, Open-Label, Randomized-Controlled Study of Abemaciclib, a CDK4 and 6 Inhibitor, in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer With Visceral Metastases
A Multicenter, Open-Label, Randomized-Controlled Study of Abemaciclib, a CDK4 and 6 Inhibitor, in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer With Visceral Metastases
Enrollment Status: Terminated
Publish Date: August 24, 2021
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

2 Total Publications

Antisense oligonucleotide targeting eukaryotic translation initiation factor 4E reduces growth and enhances chemosensitivity of non-small-cell lung cancer cells.
Antisense oligonucleotide targeting eukaryotic translation initiation factor 4E reduces growth and enhances chemosensitivity of non-small-cell lung cancer cells.
Journal: Cancer gene therapy
Published: April 17, 2015
Similar Doctors
Expertise in
39
conditions
Dr. Srivalli Gopaluni
Hematology | Oncology
Expertise in
39
conditions
Dr. Srivalli Gopaluni
Hematology | Oncology
Referral may be required
Before you request
605 East Holland Avenue, 
Spokane, WA 
 (7.1 miles away)
509-228-1000
Languages Spoken:
English, Afrikaans, Hindi, Spanish, Telugu
See accepted insurances
Accepting New Patients
Offers Telehealth

Srivalli Gopaluni is a Hematologist and an Oncologist practicing medicine in Spokane, Washington. Dr. Gopaluni is highly rated in 39 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Familial Colorectal Cancer, Pleuropulmonary Blastoma, Lung Cancer, and Bone Marrow Aspiration. Dr. Gopaluni is currently accepting new patients.

Expertise in
39
conditions
Dr. Hakan Kaya
Hematology
Expertise in
39
conditions
Dr. Hakan Kaya
Hematology
Referral may be required
Before you request
601 South Sherman Street, 
Spokane, WA 
 (0.1 miles away)
509-228-1000
Languages Spoken:
English, Hindi, Korean, Mandarin, Punjabi, Romanian, Spanish, Turkish
See accepted insurances
Accepting New Patients
Offers Telehealth

Hakan Kaya is a Hematologist practicing medicine in Spokane, Washington. Dr. Kaya is highly rated in 39 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Large-Cell Immunoblastic Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Kaya is currently accepting new patients.

Expertise in
11
conditions
Expertise in
11
conditions
Referral may be required
Before you request
101 West 8th Avenue, Suite 1400, 
Spokane, WA 
 (1.7 miles away)
509-474-2200
Languages Spoken:
English, Norwegian, Russian, Spanish, Tamil
See accepted insurances
Accepting New Patients
Offers Telehealth

Melanie Bergman is an Oncologist practicing medicine in Spokane, Washington. Dr. Bergman is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Sertoli-Leydig Cell Tumor, Ovarian Carcinosarcoma, Ureteral Reconstruction, and Salpingo-Oophorectomy. Dr. Bergman is currently accepting new patients.

Frequently Asked Questions about Dr. Saritha C. Thumma

How do I make an appointment with Dr. Saritha C. Thumma?

You can book an appointment with Dr. Saritha C. Thumma by calling their office at 509-228-1000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Saritha C. Thumma a top-rated expert for Paget Disease of the Breast?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Saritha C. Thumma is classified as an Distinguished expert for Paget Disease of the Breast, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Saritha C. Thumma specialize in?

While Dr. Saritha C. Thumma is a Hematology, they have specific expertise in Paget Disease of the Breast, Breast Cancer, and Pleuropulmonary Blastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Saritha C. Thumma participate in research or clinical trials?

Yes. Dr. Saritha C. Thumma has published 2 articles and abstracts on conditions like Paget Disease of the Breast. You can view a list of Dr. Saritha C. Thumma's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Saritha C. Thumma accept my insurance?

Dr. Saritha C. Thumma accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 509-228-1000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Thumma's expertise for a condition
ConditionClose
    View All 28 Advanced Conditions
    View All 121 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile